Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Summary

The purpose of this access protocol is to allow patients with brain tumors who had previously received 125I-MAB 425 to receive additional course(s) of 125I-MAB 425 until their brain tumor begins to grow, they develop side effects to the treatment, or their medical condition changes (e.g., you become pregnant, become infected with human immunodeficiency virus (HIV) or develop another cancer).

Timeline

Start

2010-01

Primary completion

2014-01

Completion

—

Drugs

Indications